News Clinical Data Oncology Regulatory GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer 23 March 202623 March 2026 Clinical Trials & Data Desk
Clinical Trials Healthcare & Pharmaceuticals News Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC 20 March 202620 March 2026 Clinical Trials & Data Desk
Clinical Trials Diabetes News Weight-loss Drugs Eli Lilly Declares Powerful 2% A1C Reduction and 17% Weight Loss in Landmark Phase 3 Trial Results of Retatrutide 19 March 202620 March 2026 Editor's Desk
Regulatory Approval Autoimmune Diseases News ICOTYDE FDA Approval: J&J’s First-Line Oral Peptide Breakthrough for Plaque Psoriasis Treatment 18 March 202618 March 2026 Regulatory Intelligence Desk
Clinical Trials Clinical Data News Oncology Atirmociclib Phase 2 Breakthrough: Pfizer Declares Powerful Results for Metastatic Breast Cancer Treatment 18 March 202618 March 2026 Clinical Trials & Data Desk
Clinical Trials Healthcare & Pharmaceuticals News EBGLYSS (lebrikizumab-lbkz) Delivers Remarkable Phase 3 Results for Pediatric Atopic Dermatitis Treatment 16 March 202616 March 2026 Clinical Trials & Data Desk